Oral or intravenous methylprednisolone for acute relapses of MS? (vol 349, pg 893, 1997)

被引:0
|
作者
Barkhof, F
Polman, C
机构
来源
LANCET | 1997年 / 349卷 / 9066期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1704 / 1704
页数:1
相关论文
共 50 条
  • [31] Effects of tobacco smoking on ocular smooth pursuit (vol 61, pg 349, 1997)
    Domino, EF
    Ni, LS
    Zhang, H
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (06) : 627 - 627
  • [32] Recurrent Crohn's disease in transplanted bowel (vol 349, pg 688, 1997)
    SustentoReodica
    LANCET, 1997, 350 (9073): : 298 - 298
  • [33] MODY genes and mutations in hepatocyte nuclear factors (vol 349, pg 516, 1997)
    YkiJarvinen, H
    LANCET, 1997, 349 (9057): : 1032 - 1032
  • [34] Dyspareunia and vulvodynia: Unrecognised manifestations of symptomatic dermographism (vol 349, pg 28, 1997).
    Lambiris, A
    Greaves, MW
    LANCET, 1997, 349 (9051): : 578 - 578
  • [35] Oral rather than intravenous corticosteroids should be used to treat MS relapses - Commentary
    Burton, Jodie M.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (08) : 1060 - 1062
  • [36] A Multicentric, Double Blind Randomized Clinical and MRI Study of High-Dose Oral vs Intravenous Methylprednisolone in Acute Relapses of Multiple Sclerosis
    Ramo, Cristina
    Grau, Laia
    Giner, Pilar
    Ramio, Lluis
    Brieva, Luis
    Saiz, Albert
    Cano, Antonio
    Carmona, Olga
    Martinez-Caceres, Eva
    Costa, Joan
    NEUROLOGY, 2012, 78
  • [37] Oral rather than intravenous corticosteroids should be used to treat MS relapses - Yes
    Le Page, Emmanuelle
    Edan, Gilles
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (08) : 1056 - 1058
  • [38] 3D-mapping of pressure sores (vol 349, pg 503, 1997)
    Meaume, S
    LANCET, 1997, 349 (9051): : 578 - 578
  • [39] Antibiotics for acute pyelonephritis in children (vol 20, pg 349, 2015)
    Walton, J. M.
    PAEDIATRICS & CHILD HEALTH, 2015, 20 (08) : 467 - 467
  • [40] Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials
    Liu, Shuo
    Liu, Xiaoqiang
    Chen, Shuying
    Xiao, Yingxiu
    Zhuang, Weiduan
    PLOS ONE, 2017, 12 (11):